Fetal glucocorticoid-regulated pathways are not affected by inhaled corticosteroid use for asthma during pregnancy

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 6, 2011, Pages 716-722

  Hodyl, Nicolette A ^a   Stark, Michael J ^a   Osei Kumah, Annette ^a   Bowman, Maria ^b   Gibson, Peter ^c   Clifton, Vicki L ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Asthma; Corticotropin releasing hormone; Cortisol; Inhaled corticosteroids; Pregnancy

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; ESTRIOL; GLUCOCORTICOID; HYDROCORTISONE; OSTEOCALCIN;

ADRENAL FUNCTION; ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; ECHOGRAPHY; ESTRIOL BLOOD LEVEL; FEMALE; FETUS DEVELOPMENT; FETUS GROWTH; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CASE-CONTROL STUDIES; CORTICOTROPIN-RELEASING HORMONE; ESTRIOL; FEMALE; FETAL DEVELOPMENT; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MALE; OSTEOCALCIN; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; SEX FACTORS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 79952726454     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201007-1188OC     Document Type: Article

References (51)

1. Kwon HL, Belanger K, Bracken MB. Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol 2003;13:317-324. (Pubitemid 36765394)
2. Australian Centre for Asthma Monitoring. Asthma in Australia 2008, in AIHW Asthma Series, AIHW, editor. Canberra: Australian Institute for Health and Welfare; 2008.
3. Bahna SL, Bjerkedal T. The course and outcome of pregnancy in women with bronchial asthma. Acta Allergol 1972;27:397-406.
4. Stenius-Aarniala B, Piirila P, Teramo K. Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax 1988;43:12-18. (Pubitemid 18031928)
5. Demissie K, Breckenridge MB, Rhoads GG. Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med 1998;158:1091-1095. (Pubitemid 28489006)
6. Breton MC, Beauchesne MF, Lemiere C, Rey E, Forget A, Blais L. Riskof perinatal mortality associated with asthma during pregnancy. Thorax 2009;64:101-106.
7. Kallen B, Rydhstroem H, Aberg A. Asthma during pregnancy-a population based study. Eur J Epidemiol 2000;16:167-171. (Pubitemid 30322123)
8. Kallen B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 2. Infant characteristics excluding congenital malformations. Eur J Clin Pharmacol 2007;63:375-381.
9. Enriquez R, Griffin MR, Carroll KN, Wu P, Cooper WO, Gebretsadik T, Dupont WD, Mitchel EF, Hartert TV. Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes. J Allergy Clin Immunol 2007;120:625-630. (Pubitemid 47320762)
10. Wen SW, Demissie K, Liu S. Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population. Ann Epidemiol 2001;11:7-12. (Pubitemid 32054784)
11. Murphy VE, Gibson PG, Giles WB, Zakar T, Smith R, Bisits AM, Kessell CG, Clifton VL. Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med 2003;168:1317-1323. (Pubitemid 37487326)
12. Perlow JH, Montgomery D, Morgan MA, Towers CV, Porto M. Severity of asthma and perinatal outcome. Am J Obstet Gynecol 1992;167:963-967.
13. Kallen B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol 2007;63:363-373.
14. Blais, L., Beauchesne MF, Lemiere C, Elftouh N. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. J Allergy Clin Immunol 2009;124:1229-1234.e4.
15. Clifton VL, Engel P, Smith R, Gibson P, Brinsmead M, Giles WB. Maternal and neonatal outcomes of pregnancies complicated by asthma in an Australian population. Aust N Z J Obstet Gynaecol 2009;49:619-626.
16. Bakhireva LN, Schatz M, Jones KL, Chambers CD. Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth. Ann Allergy Asthma Immunol 2008;101:137-143.
17. Murphy VE, Gibson PG, Smith R, Clifton VL. Asthma during pregnancy: mechanisms and treatment implications. Eur Respir J 2005;25:731-750. (Pubitemid 40528770)
18. Schatz M, Leibman C. Inhaled corticosteroid use and outcomes in pregnancy. Ann Allergy Asthma Immunol 2005;95:234-238. (Pubitemid 41376792)
19. National Asthma Council Australia. Asthma management handbook (revised and updated). South Melbourne: Asthma Management Council of Australia Ltd. 2006.
20. National Asthma Education and Prevention Program. Quick reference from the Working Group Report on asthma during pregnancy: recommendations for pharmacological treatment. Update 2004. In: NIH Publication No. 05-3279. Bethesda, MD: US Department of Health and Human Services; National Institutes of Health; National Heart, Lung and Blood Institute. 2004.
21. Murphy VE, Gibson PG, Talbot PI, Kessell CG, Clifton VL. Asthma self-management skills and the use of asthma education during pregnancy. Eur Respir J 2005;26:435-441. (Pubitemid 41264205)
22. Chambers K. Asthma education and outcomes for women of child-bearing age. Case Manager 2003;14:58-61.
23. Mesquita AR, Wegerich Y, Patchev AV, Oliveira M, Leao P, Sousa N, Almeida OF. Glucocorticoids and neuro- and behavioural development. Semin Fetal Neonatal Med 2009;14:130-135.
24. Haning RV Jr, Curet LB, Poole WK, Boehnlein LM, Kuzma DL, Meier SM. Effects of fetal sex and dexamethasone on preterm maternal serum concentrations of human chorionic gonadotropin, progesterone, estrone, estradiol, and estriol. Am J Obstet Gynecol 1989;161:1549-1553. (Pubitemid 20024030)
25. Hendershott CM, Dullien V, Goodwin TM. Serial betamethasone administration: effect on maternal salivary estriol levels. Am J Obstet Gynecol 1999;180:S219-S222. (Pubitemid 29072385)
26. Patrick J, Challis J, Natale R, Richardson B. Circadian rhythms in maternal plasma cortisol, estrone, estradiol, and estriol at 34 to 35 weeks' gestation. Am J Obstet Gynecol 1979;135:791-798. (Pubitemid 10236406)
27. Maltau JM, Stokke KT, Moe N. Effects of betamethasone on plasma levels of estriol, cortisol and HCS in late pregnancy. Acta Obstet Gynecol Scand 1979;58:235-238. (Pubitemid 9231744)
28. Grammatopoulos DK. Placental corticotrophin-releasing hormone and its receptors in human pregnancy and labour: still a scientific enigma. J Neuroendocrinol 2008;20:432-438.
29. Korebrits C, Yu DH, Ramirez MM, Marinoni E, Bocking AD, Challis JR. Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma. Br J Obstet Gynaecol 1998;105:556-561. (Pubitemid 28261388)
30. Wlodarczyk JH, Gibson PG, Caeser M. Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: a quantitative review. Ann Allergy Asthma Immunol 2008;100:23-30.
31. Martin RJ, Szefler SJ, Chinchilli VM, Kraft M, Dolovich M, Boushey HA, Cherniack RM, Craig TJ, Drazen JM, Fagan JK, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002;165:1377-1383. (Pubitemid 34522940)
32. Richy F, Bousquet J, Ehrlich GE, Meunier PJ, Israel E, Morii H, Devogelaer JP, Peel N, Haim M, Bruyere O, et al. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int 2003;14:179-190. (Pubitemid 40826230)
33. Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991;88:572-580.
34. Toogood JH. Inhaled steroids for chronic asthma. Hosp Pract (Off Ed) 1991;26:15-18, 23, 26.
35. Clifton VL, Murphy VE. Maternal asthma as a model for examining fetal sex-specific effects on maternal physiology and placental mechanisms that regulate human fetal growth. Placenta 2004;25:S45-S52. (Pubitemid 38514956)
36. Clifton VL, Hodyl NA, Murphy VE, Giles WB, Baxter RC, Smith R. Effect of maternal asthma, inhaled glucocorticoids and cigarette use during pregnancy on the newborn insulin-like growth factor axis. Growth Horm IGF Res 2010;20:39-48.
37. Hodyl N, Wyper H, Osei-Kumah A, Scott N, Murphy VE, Gibson P, Smith R, Clifton VL. Sex-specific associations between cortisol and birth weight in pregnancies complicated by asthma are not due to differential glucocorticoid receptor expression. Thorax 2010;65:677-683.
38. Murphy VE, Clifton VL. Alterations in human placental 11B-hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour. Placenta 2003;24:739-744. (Pubitemid 37184796)
39. Murphy VE, Zakar T, Smith R. Reduced 11B-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol Metab 2002;87:1660-1668. (Pubitemid 34615254)
40. Scott NM, Hodyl NA, Murphy VE, Osei-Kumah A, Wyper H, Hodgson DM, Smith R, Clifton VL. Placental cytokine expression covaries with maternal asthma severity and fetal sex. J Immunol 2009;182:1411-1420.
41. Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary- adrenal axis in adult patients with asthma. Clin Ther 1999;21:353-367. (Pubitemid 29157793)
42. Chan EC, Smith R, Lewin T, Brinsmead MW, Zhang HP, Cubis J, Thornton K, Hurt D. Plasma corticotropin-releasing hormone, beta-endorphin and cortisol inter-relationships during human pregnancy. Acta Endocrinol (Copenh) 1993;128:339-344. (Pubitemid 23128004)
43. Brus R. Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults. Arch Intern Med 1999;159:1903-1908. (Pubitemid 29424710)
44. Grebe SK, Feek CM, Durham JA, Kljakovic M, Cooke RR. Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent manner. Clin Endocrinol (Oxf) 1997;47:297-304. (Pubitemid 27395960)
45. Clark DJ, Lipworth BJ. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. Chest 1997;112:1248-1252. (Pubitemid 27497855)
46. Clark DJ, Lipworth BJ. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax 1997;52:55-58. (Pubitemid 27047226)
47. Peters SP. Safety of inhaled corticosteroids in the treatment of persistent asthma. J Natl Med Assoc 2006;98:851-861. (Pubitemid 43846242)
48. Edwards CR, Benediktsson R, Lindsay RS, Seckl JR. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet 1993;341:355-357.
49. Murphy VE, Fittock RJ, Zarzycki PK, Delahunty MM, Smith R, Clifton VL. Metabolism of synthetic steroids by the human placenta. Placenta 2007;28:39-46. (Pubitemid 44734614)
50. Wendel PJ, Ramin SM, Barnett-Hamm C, Rowe TF, Cunningham FG. Asthma treatment in pregnancy: a randomized controlled study. Am J Obstet Gynecol 1996;175:150-154. (Pubitemid 26282221)
51. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002;57:880-884. (Pubitemid 35178613)